Search for: "Takeda Pharmaceuticals America, Inc. "
Results 41 - 60
of 65
Sort by Relevance
|
Sort by Date
2 Dec 2012, 8:32 pm
Lupin Ltd. et al. 3:12-cv-07333; filed November 29, 2012 in the District Court of New Jersey • Plaintiffs: Takeda Pharmaceutical Co.; Takeda Pharmaceuticals U.S.A., Inc; Takeda Pharmaceuticals LLC; Takeda Pharmaceuticals America, Inc. [read post]
25 Oct 2012, 9:20 pm
Another dangerous drug lawsuit has been filed against Takeda Pharmaceuticals claiming that the drug Actos caused 14 plaintiffs to develop bladder cancer. [read post]
5 Sep 2012, 3:30 pm
Meantime, more people are coming forward to file their Actos lawsuits against drug maker Takeda Pharmaceuticals, its subsidiaries, and Eli Lilly, which has been active in marketing the diabetes drug in the US. [read post]
13 Aug 2012, 7:02 pm
FDA Drug Safety Communication: Selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in newborn babies, FDA, December 14, 2011 Selective serotonin reuptake inhibitors, Mayo Clinic Birth Defects, Centers for Disease Control and Prevention More Blog Posts: Actos Lawsuits Allow Diabetes Patients to Pursue Dangerous Drug Compensation from Takeda Pharmaceuticals America, Inc., Drug Injury… [read post]
8 Aug 2012, 8:30 pm
(BSX), Murray Hill, Johnson & Johnson (JNJ), Endo Pharmaceutical Holdings Inc., and other companies. [read post]
1 Aug 2012, 11:17 am
Throughout the US, Altman & Altman, LLP represents clients with Actos lawsuits against manufacturer Takeda Pharmaceuticals America, Inc. [read post]
27 Jan 2012, 7:13 am
As a result, the FDA ordered the drug’s manufacturer, Takeda Pharmaceuticals North America, Inc., to update Actos symptoms on the drug’s label earlier this fall. [read post]
8 Jan 2012, 9:05 pm
Mylan, Inc. et al. 1:12-cv-00024; filed January 3, 2011 in the Southern District of New York • Plaintiffs: Takeda Pharmaceutical Co.; Takeda Pharmaceuticals North America, Inc.; Takeda Global Research and Development Center, Inc.; Watson Pharmaceuticals, Inc.; Andrx Labs, LLC • Defendants: Mylan, Inc.; Mylan Pharmaceuticals, Inc. [read post]
5 Jan 2012, 3:10 pm
In August, Plaintiffs with pending lawsuits against Japanese company Takeda Pharmaceuticals America Inc. [read post]
4 Jan 2012, 9:20 am
In August, Plaintiffs with pending lawsuits against Japanese company Takeda Pharmaceuticals America Inc. [read post]
3 Jan 2012, 5:38 pm
MDL Consolidation to eliminate duplicative discovery, prevent inconsistent pretrial rulings, and conserve the resources of the parties, their counsel and the judiciary Actos (pioglitazone) was marketed by Takeda Pharmaceuticals America Inc. and Eli Lilly and Co. in 1999 for the treatment of Type II diabetes. [read post]
17 Oct 2011, 9:03 am
Takeda Pharmaceuticals North America Inc. et al., 1:09-cv-1086 (E.D. [read post]
19 Sep 2011, 6:49 am
Notwithstanding the serious risk, the manufacturer of ACTOS, Takeda Pharmaceuticals North America Inc., has told reporters that the company remains positive about the drug. [read post]
18 Sep 2011, 9:55 pm
Accord Healthcare, Inc. 1:11-cv-06360; filed September 12, 2011 in the Southern District of New York • Plaintiffs: Takeda Pharmaceutical Co.; Takeda Pharmaceuticals North America, Inc. [read post]
17 Sep 2011, 5:43 am
The lawsuit alleges that Actos' manufacturer, Takeda Pharmaceuticals North America (and other entities including: Takeda Global Research & Development Center Inc., Takeda Pharmaceuticals Company Ltd., Takeda Pharmaceuticals America, Takeda San Diego Inc., Takeda Pharmaceuticals International Inc and Eli Lilly and Company), was negligent for not providing any… [read post]
5 Aug 2011, 2:27 pm
European Drug Regulator EMA Recommended New Actos Contra-Indications And Warnings In July 2011 (Posted by Tom Lamb at DrugInjuryWatch.com) On August 4, 2011 we learned that Takeda Pharmaceuticals America, Inc. had revised the prescribing information -- also called the package insert or label -- for its diabetes drug Actos (pioglitazone) and other anti-diabetic pioglitazone-containing medicines by means of this item, "FDA Drug Safety Communication: Updated… [read post]
16 Jun 2011, 7:07 am
Food and Drug Administration today announced it has begun a safety review of the diabetes drug Actos (pioglitazone), after receiving preliminary results from a long-term observational study designed to evaluate the risk of bladder cancer associated with use of this drug.The preliminary results are based on five-year data from an ongoing, 10-year observational study by the manufacturer, Takeda Pharmaceuticals North America Inc., San Diego. [read post]
1 Jul 2010, 1:32 pm
Novartis Pfizer Sanofi-Aventis Takeda Pharmaceuticals [read post]
18 Dec 2009, 9:59 am
(patent infringement) 12/2: Takeda Pharmaceutical Company Ltd. and Takeda Pharmaceutical North America Inc. v. [read post]
9 Dec 2009, 3:59 pm
Teva Pharmaceuticals USA Inc. [read post]
